Acute exacerbations of idiopathic pulmonary fibrosis

…, T Johkoh, N Kaminski, DS Kim, Y Kondoh… - American journal of …, 2007 - atsjournals.org
The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady,
predictable decline in lung function over time. Recent evidence suggests that some …

Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report

…, TJ Corte, G Jenkins, Y Kondoh… - American journal of …, 2016 - atsjournals.org
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

Palliative care in interstitial lung disease: living well

…, R Kairalla, M Kolb, Y Kondoh… - The Lancet …, 2017 - thelancet.com
Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

…, T Johkoh, DS Kim, TE King Jr, Y Kondoh… - American journal of …, 2011 - atsjournals.org
This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …

Pirfenidone in idiopathic pulmonary fibrosis

H Taniguchi, M Ebina, Y Kondoh… - European …, 2010 - Eur Respiratory Soc
… Taniguchi H, Kondoh Y. Revised criteria for acute exacerbation of idiopathic pulmonary
fibrosis. The Annual Report by Study Group of Ministry of Health and Welfare for Diffuse Lung …

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …

…, K Kishi, H Kitamura, M Kolb, Y Kondoh… - The lancet Respiratory …, 2020 - thelancet.com
Background The INBUILD trial investigated the efficacy and safety of nintedanib versus
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …

Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases

Y Kondoh, H Taniguchi, Y Kawabata, T Yokoi, K Suzuki… - Chest, 1993 - Elsevier
We treated three patients with idiopathic pulmonary fibrosis who had an acute clinical
exacerbation. We analyzed their clinical, radiographic, therapeutic, and pathologic findings. Their …

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation

…, T Amemiya, Y Kondoh, H Tashiro, Y Okazaki - Biochemical and …, 2008 - Elsevier
Although various microRNAs regulate cell differentiation and proliferation, no miRNA has
been reported so far to play an important role in the regulation of osteoblast differentiation. …

miR‐210 promotes osteoblastic differentiation through inhibition of AcvR1b

…, Y Kondoh, T Amemiya, H Tashiro, Y Okazaki - FEBS …, 2009 - Wiley Online Library
Although microRNAs (miRNAs) are involved in many biological processes, the mechanisms
whereby miRNAs regulate osteoblastic differentiation are poorly understood. Here, we …

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

O Nishiyama, Y Kondoh, T Kimura, K Kato… - …, 2008 - Wiley Online Library
Background and objective: Although pulmonary rehabilitation is effective for patients with
COPD, its efficacy in patients with IPF is unknown. The purpose of this study was to evaluate …